Skip to main content

Minimally Invasive Surgical Systems Market New Industry Research on Future Growth and Analysis Prospects to 2031


 

As per the National Cancer Institute, minimally invasive surgery is defined as, “surgery that is done using small incisions (cuts) and few stitches. During minimally invasive surgery, one or more small incisions may be made in the body. A laparoscope (thin, tube-like instrument with a light and a lens for viewing) is inserted through one opening to guide the surgery. Tiny surgical instruments are inserted through other openings to do the surgery. Minimally invasive surgery may cause less pain, scarring, and damage to healthy tissue, and the patient may have a faster recovery than with traditional surgery.”

The global  minimally invasive surgical systems market  is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.

Impact of COVID-19

The COVID-19 pandemic had a huge impact on elective surgical procedures in the first half of 2020. The COVID-19 pandemic has drastically impacted the daily hospital routine services on the global level. During the initial phase of the pandemic, hospitals greatly reduced or canceled conducting elective surgical procedures for patient safety and to prioritize the care treatments for patients with COVID?19.

The reduction in the volume of elective surgical procedures on a large scale had a substantial impact on patients as well as a financial impact on the medical device manufacturers. This resulted in the decreased sales of the minimally invasive surgical systems.

Market Segmentation

Minimally Invasive Surgical Systems Market (by Product Type)

Under this segmentation, the market in divided into conventional technologies and surgical robotics.

The conventional technologies segment dominates the market with a share of 80.4% of global minimally invasive surgical systems market mainly due to the increase in the number of minimally invasive surgical procedures.

Minimally Invasive Surgical Systems Market (by Application)

Under this segmentation, the market in divided into general surgery, urology surgery, orthopedic surgery, cardiovascular surgery, neurosurgery, others (cosmetic and bariatric surgery)

These above-mentioned applications are based on conventional technologies and surgical robotics segment.

Orthopedic surgery under the conventional technology segment is expected to register the highest CAGR of 7.0% during the forecast period.

Minimally Invasive Surgical Systems Market (by End-User)

Under this segmentation, the market in divided into hospitals, ambulatory surgical centers (ABCs), specialty clinics.

The hospitals segment dominates the minimally invasive surgical systems market with a share of 73.3% of global market mainly due to the number of hospitals providing access to the surgical treatments for the patients.

Ambulatory surgical centers (ASCs) segment is expected to register the highest CAGR of 8.0% during the forecast period.

Minimally Invasive Surgical Systems Market (by Region)

The different regions covered under the market report includes North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

North America dominates the market in 2020 and is anticipated to uphold its dominance throughout the forecast period. The growth in the market is majorly driven by the increasing research and development activities and many companies being located in the U.S.

Latin America, and Middle East and Africa market is expected to grow with the highest CAGR of 7.8% during the forecast period.

Market Drivers

Presently, the factors driving the growth of the market as per the minimally invasive surgical systems report include rising incidence of chronic diseases, increase in global geriatric population, advantages of MIS over open surgeries, increasing healthcare costs, technological advancements in surgical procedures and technologies.

Market Challenges

The challenges that are restricting the growth of the market include high cost of surgical robotics systems, shortage of skilled professionals, and restrictive reimbursement landscape.

High cost of the surgical robotic system is among the most challenging factors for the end-user to buy and treatment for patients. It has been observed that many patients prefer international travel for their surgeries to take the advantage of currency rate. Also, due to the shortage of skilled professionals have led to a slight increase in the expense of the robotic surgery. Restrictive reimbursement landscape is another factor affecting the growth of the global minimally invasive surgical systems market.

Market Opportunities

Potential opportunities that are likely to increase the growth of the market include development of low-cost surgical robotic systems, development of surgical simulators for the training of professionals, and engagement in mergers and acquisitions to diversify the endoscopic portfolio.

The current radiation therapy systems have a price of around $2 million, therefore many companies are working in developing cost-effective system and even working towards the development of a low-cost surgical robotic platform. And with time, technologically advanced products are being working, researched to get an upgraded product.

Key Market Players and Competition Synopsis

Some of the key players operating in the market include Arthrex Inc., Asensus Surgical Inc. (formerly TransEnterix Inc.), Boston Scientific Corporation, Conmed Corporation, Fujifilm Holdings Corporation, Intuitive Surgical Inc., Karl Storz SE Co. KG, Medtronic plc, Olympus Corporation, Hoya Corporation (Pentax Medical), Siemens Healthineers AG, Smith Nephew plc, Sony Corporation, Stryker Corporation, Zimmer Biomed Holdings Inc.

Key questions answered in the Report

• What are the key regulations governing the minimally invasive surgical systems market, across the globe?

• What are the key technological developments on which the current industry leaders are spending their major share of research and development (RD) investment?

• How is the role of minimally invasive surgery technologies expected to evolve in the future?

• Who are the leading players who hold significant dominance on the global minimally invasive surgical systems market, currently?

• How likely are current business models to persist in the future?

• What are the key market drivers, challenges, growth opportunities, and trends?

• How do minimally invasive procedures function as compared to each other?

• How is the expiration of patents likely to disrupt the market dynamics?

• What are the key strategies incorporated by the leading players in the minimally invasive surgical systems landscape?

• What is the likelihood of new players entering the market in near term?

• What is the current revenue contribution for different endoscopes and endoscopy systems, and what are the expected modifications in the forecast period?

• What is the current revenue contribution for the different types of conventional minimally invasive surgical systems, and what are expected modifications in the same forecast period?

• What is the current revenue contribution for the different types of surgical robotic systems, and what are the expected modifications in the same forecast period?

• Which countries contribute to the largest share of current demand and which countries hold significant scope for business expansion activities, by the key players?

 

Request a Sample -  https://bisresearch.com/requestsample?id=1259type=download

The scope of the research study titled global minimally invasive surgical systems market is aimed at assessing the market potential for both conventional minimally invasive surgical systems (MISS) and surgical robotics technologies. Following were the types of approaches in which the minimally invasive surgical systems market was estimated, and its growth potential for the forecast period was evaluated. The report also includes pre, during, and future impact of COVID-19 on the global minimally invasive surgical market with emphasis on procedure volume and hospital procurement.

BIS Related Studies

Global Surgical Robotics Market

Global Minimally Invasive Gastrointestinal Surgical Systems Market

Comments

Popular posts from this blog

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applicatio

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring.   Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth.  The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030.   The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of

Neoantigen Cancer Vaccine Market Technology Developments and Future Growth

  Looking at the recent oncology care trends, the World Heart Foundation estimates the global cancer treatment expenditure to reach $XX billion in the year 2031.   The increase in overall burden provides an opportunity for several companies to step in and introduce their innovative products in the market. The emergence of the neoantigen cancer vaccine can be considered as an evident example of emerging oncology care that can possibly prevail over the existing hurdles of treatment un-specificity and safety benchmarks. The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031. The  neoantigen cancer vaccine market  is expected to generate $35.5 million in revenue in 2024, owing to the expected launch of the first neoantigen vaccine, DC vaccine in the market. The neoantigen cancer vaccine market growth has been primarily attributed to major drivers in this market, such as rising p